CurrentCardio coverage · page 3 of 17
European Heart Journal
Latest from European Heart Journal
Eur Heart J
Interleukin-6 and C-reactive protein prognostic value following acute coronary syndrome
Secondary analysisCoronary & ACS
Eur Heart J
Pathophysiology, prevention, and management of coronary microvascular obstruction
Guideline or statementCoronary & ACS
Eur Heart J
Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statement
Guideline or statementPrevention & lipids
Eur Heart J
Obicetrapib and lipoprotein(a) levels in patients at high cardiovascular risk: a pooled analysis of trials
Meta-analysisPrevention & lipids
Eur Heart J
Eur Heart J
Eur Heart J
Eur Heart J
Eur Heart J
Preservative food additives, hypertension, and cardiovascular diseases: the NutriNet-Santé study
Cohort studyHypertension
Eur Heart J
European Society of Cardiology: cardiovascular disease statistics 2025
Research articleCardio-oncology & other
Eur Heart J
Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differences
Meta-analysisCoronary & ACS
Eur Heart J
Homozygous familial hypercholesterolaemia: insights from the Global HICC Registry
Cohort studyPrevention & lipids
Eur Heart J
Eur Heart J
Eur Heart J
MTMR4 variants have opposite gene-specific impact on life-threatening arrhythmic risk in type 1 and 2 long QT syndrome
Research articleArrhythmias & EP
Eur Heart J
Eur Heart J
Outcomes after a first acute myocardial infarction in patients with or without congenital heart disease
Case-control studyCoronary & ACS
Eur Heart J
Eur Heart J
Environmental risk factors and cardiovascular health
Guideline or statementPrevention & lipids
Eur Heart J
Ultra-processed foods, lifestyle management, and cardiovascular diseases: A clinical consensus statement of the European Society of Cardiology Council for Cardiology Practice and the European Association of Preventive Cardiology of the European Society of Cardiology
Guideline or statementPrevention & lipids
Eur Heart J
A nurse-coordinated intervention programme vs standard of care after an acute coronary syndrome: the ALLEPRE trial
Randomised controlled trialCoronary & ACS
Eur Heart J
Cancer and heart failure: prevalence, incidence, and prognosis in Scotland
Cohort studyHeart failure
Eur Heart J
Eur Heart J
Multi-modality non-invasive cardiovascular screening and sex-specific outcomes: the Viborg Screening Program
Cohort studyPrevention & lipids
Eur Heart J
Sex differences in pharmacological treatment of heart failure: a meta-analysis of randomized trials
Meta-analysisHeart failure
Eur Heart J
Eur Heart J
Eur Heart J
Stereotactic arrhythmia radioablation for refractory ventricular tachycardia: the STOPSTORM.eu study
Cohort studyArrhythmias & EP
Eur Heart J
Cardiac resynchronization therapy with or without atrioventricular node ablation in atrial fibrillation: the CAAN-AF trial
Randomised controlled trialHeart failure
Eur Heart J
Eur Heart J
Left bundle branch area vs biventricular pacing for cardiac resynchronization therapy: the LEFT-BUNDLE-CRT trial
Randomised controlled trialHeart failure
Eur Heart J
Ultrasound-guided vs conventional venous puncture for atrial fibrillation ablation: the ULYSSES trial
Randomised controlled trialArrhythmias & EP
Eur Heart J
Cardiac evaluation of paediatric athletes
Guideline or statementArrhythmias & EP
Eur Heart J
New-onset postoperative atrial fibrillation management and outcomes: the VISION Cardiac Surgery cohort
Cohort studyArrhythmias & EP
Eur Heart J
Eur Heart J
Eur Heart J
Eur Heart J
Stroke and systemic embolism following atrial fibrillation ablation: the EMBOL-AF Global Registry
Cohort studyArrhythmias & EP
Eur Heart J
Volume vs intensity of physical activity and risk of cardiovascular and non-cardiovascular chronic diseases
Cohort studyPrevention & lipids
Eur Heart J
Tricuspid regurgitation: standardized stepwise work-up from referral to expert heart valve centre
Research articleValvular & structural